The Record header image

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

July 2024

Requirements, codes changed for some medical benefit drugs

Blue Cross Blue Shield of Michigan and Blue Care Network encourage proper utilization of high-cost medications that are covered under medical benefits. As part of this effort, we maintain comprehensive lists of requirements for our members.

In April, May and June 2024, we added requirements for some medical benefit drugs. These requirements went into effect on various dates. In addition, some drugs were assigned new HCPCS codes.

Changes in requirements

For Blue Cross and BCN commercial members, we added prior authorization requirements for the following drugs:

HCPCS code

Brand name

Generic name

J3590**

Beqvez™

Fidanacogene elaparvovec-dzkt

J3590**

Bkemv™ IV

Eculizumab-aeeb

J3590**

Hercessi™

Trastuzumab

J3590**

Opuviz™

Aflibercept-yszy

J3590**

Yesafili™

Aflibercept-jbvf

For Medicare Plus Blue℠ and BCN Advantage℠ members, we added prior authorization requirements for the following drugs:

HCPCS code

Brand name

Generic name

For dates of service on or after

J1599

Alyglo™

Immune globulin intravenous, human-stwk 10%

April 1, 2024

J3590**

Amtagvi™

Lifileucel

April 1, 2024

J3590**

Avzivi®

Bevacizumab-tnjn

April 1, 2024

J1931

Ryzneuta®

Efbemalenograstim alfa-vuxw

April 1, 2024

Q5111

Udenyca® Onbody

Pegfilgrastim-cbqv

April 1, 2024

Q5133

Tofidence™

Tocilizumab-bavi

May 1, 2024

J3590**

Winrevair™

Sotatercept-csrk

May 1, 2024

J3590**

Beqvez™

Fidanacogene elaparvovec-dzkt

June 1, 2024

Code changes

The table below shows HCPCS code changes that were effective January 2024 for the medical benefit drugs managed by Blue Cross and BCN.

New HCPCS code

Brand name

Generic name

J0177

Eylea® HD

Aflibercept

J0589

Daxxify®

Daxibotulinumtoxin A

J1203

Pombiliti™

Cipaglucosidase alfa-atga

J2782

Izervay™

Avacincaptad pegol

J9376

Veopoz™

Pozelimab-bbfg

Drug lists

For additional details, see the following drug lists:

These lists are also available on the following pages of the ereferrals.bcbsm.com website:

Additional information about these requirements

We communicated these changes previously through provider alerts. Those alerts contain additional details.

You can view the provider alerts on ereferrals.bcbsm.com and on our Provider Resources site, which is accessible through our provider portal (availity.com).***

Additional information for Blue Cross commercial groups

For Blue Cross commercial health plans, authorization requirements apply only to groups that participate in the standard commercial Medical Drug Prior Authorization Program for drugs administered under medical benefits.

To determine whether a group participates in the prior authorization program, see the Specialty Pharmacy Prior Authorization Master Opt-in/out Group List. A link to this list is also available on the Blue Cross Medical Benefit Drugs page of the ereferrals.bcbsm.com website.

Note: Blue Cross and Blue Shield Federal Employee Program® members and UAW Retiree Medical Benefits Trust (non-Medicare) members don't participate in the standard prior authorization program.

Reminder

An authorization approval isn’t a guarantee of payment. Health care providers need to verify eligibility and benefits for members.

**May be assigned a unique code in the future

***Blue Cross Blue Shield of Michigan doesn’t own or control this website.

Availity® is an independent company that contracts with Blue Cross Blue Shield of Michigan and Blue Care Network to offer provider portal and electronic data interchange services.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2023 American Medical Association. All rights reserved.